日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Design, synthesis, characterization, in silico studies, and in vitro anticancer evaluation of novel 7-methoxyquinolone-substituted triazole hybrids

新型7-甲氧基喹诺酮取代三唑杂合物的设计、合成、表征、计算机模拟研究和体外抗癌评价

Allıto, Lemıye; Comert Onder, Ferah; Demirel, Ramazan; Onder, Alper; Özden, Özkan; Erdoğan, Musa

New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers

用于治疗阿尔茨海默病和癌症的新型及潜在含硼化合物

Comert Onder, Ferah; Ural, Kadircan; Onder, Alper; Ozpolat, Bulent; Ay, Mehmet

Novel benzothiazole/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies.

新型苯并噻唑/苯并噻唑噻唑烷-2,4-二酮衍生物作为潜在的FOXM1抑制剂:计算机模拟、合成和体外研究

Abusharkh Khaled A N, Comert Onder Ferah, Çınar Venhar, Onder Alper, Sıkık Merve, Hamurcu Zuhal, Ozpolat Bulent, Ay Mehmet

A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells

一项药物再利用研究发现了具有体外抗乳腺癌细胞活性的新型 FOXM1 抑制剂

Khaled A N Abusharkh, Ferah Comert Onder, Venhar Çınar, Zuhal Hamurcu, Bulent Ozpolat, Mehmet Ay

Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy

新型依托度酸衍生物作为真核延伸因子2激酶(eEF2K)抑制剂用于靶向癌症治疗

Comert Onder, Ferah; Siyah, Pinar; Durdagi, Serdar; Ay, Mehmet; Ozpolat, Bulent

Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo

基于香豆素查尔酮骨架的新型EF2激酶抑制剂的靶向设计可抑制体内乳腺癌细胞的生长

Comert Onder, Ferah; Kahraman, Nermin; Bellur Atici, Esen; Cagir, Ali; Kandemir, Hakan; Tatar, Gizem; Taskin Tok, Tugba; Kara, Goknur; Karliga, Bekir; Durdagi, Serdar; Ay, Mehmet; Ozpolat, Bulent